The ownership structure of Eiger Biopharmaceuticals (EIGRQ) stock is a mix of institutional, retail, and individual investors. , and 99.61% is owned by Public Companies and Individual Investors.
The ownership structure of Eiger Biopharmaceuticals (EIGRQ) stock is a mix of institutional, retail, and individual investors. Approximately 99.98% of the company’s stock is owned by Institutional Investors, 0.02% is owned by Insiders
Top Shareholders
Holder
# of Shares
Type
% Holding
Value
90,000
Institution
0.37%
―
4,542
Institution
0.02%
―
Top Mutual Fund Holders
Holder
# of Shares
Type
% Holding
Value
4,542
Institution
0.02%
―
Top ETF Holders
Holder
# of Shares
Type
% Holding
Value
FAQ
Who Owns Eiger Biopharmaceuticals, Inc. (EIGRQ)?
Currently, no data Available
What percentage of Eiger Biopharmaceuticals, Inc. (EIGRQ) stock is held by institutional investors?
Currently, no data Available
What percentage of Eiger Biopharmaceuticals, Inc. (EIGRQ) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.61% of Eiger Biopharmaceuticals, Inc. (EIGRQ) stock is held by retail investors.
Who owns the most shares of Eiger Biopharmaceuticals, Inc. (EIGRQ)?
Simplify owns the most shares of Eiger Biopharmaceuticals, Inc. (EIGRQ).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.